ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
3,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
5,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5,3,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
6,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
6,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
6,5,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
6,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
7,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
8,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
8,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
8,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
9,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
10,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
10,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
10,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
11,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
11,2,Coronary artery bypass,Arterial therapeutic procedures (excl aortic),Vascular therapeutic procedures,Surg,N
11,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
12,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
12,2,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
12,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
13,1,Aminoaciduria,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
13,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
13,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
13,4,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
13,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
13,6,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
13,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
13,8,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
13,9,Urine phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
14,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
14,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
14,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
14,4,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
14,5,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
14,6,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
14,7,Bone hypertrophy,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
14,8,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
14,9,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
14,10,Hepatitis B e antigen,Virus identification and serology,Microbiology and serology investigations,Inv,N
14,11,Intervertebral disc degeneration,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
14,12,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
14,13,Nephrocalcinosis,Renal lithiasis,Urolithiases,Renal,N
14,14,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
14,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
14,16,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
14,17,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
14,18,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
14,19,Sacral pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
14,20,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
14,21,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
14,22,Urine phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
15,1,Blood bilirubin abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
15,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
15,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
16,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
16,2,Angiodysplasia,Vascular malformations and acquired anomalies,Vascular disorders NEC,Vasc,N
16,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
16,4,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
16,5,Large intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
16,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
16,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
16,8,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
16,9,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
17,1,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
17,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
18,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
19,1,Hyperphosphatasaemia,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
19,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
20,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
20,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
20,3,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
20,4,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
20,5,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
21,1,Hypophosphataemic osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
22,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
22,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
22,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
22,4,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
22,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
22,6,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
22,7,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
23,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
23,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
